Cited by 52Gastroesophageal reflux and treatmentsGastrointestinal motility and disordersEsophageal Cancer Research and Treatment

Esophageal motor dysfunctions in gastroesophageal reflux disease and therapeutic perspectives

Open access
Lin, Sihui, Li, Hua, Fang, Xiucai·2019·Journal of Neurogastroenterology and Motility

Abstract

Gastroesophageal reflux disease (GERD) is a very common disease, and the prevalence in the general population has recently increased. GERD is a chronic relapsing disease associated with motility disorders of the upper gastrointestinal tract. Several factors are implicated in GERD, including hypotensive lower esophageal sphincter, frequent transient lower esophageal sphincter relaxation, esophageal hypersensitivity, reduced resistance of the esophageal mucosa against the refluxed contents, ineffective esophageal motility, abnormal bolus transport, deficits initiating secondary peristalsis, abnormal response to multiple rapid swallowing, and hiatal hernia. One or more of these mechanisms result in the reflux of stomach contents into the esophagus, delayed clearance of the refluxate, and the development of symptoms and/or complications. New techniques, such as 24-hour pH and multichannel intraluminal impedance monitoring, multichannel intraluminal impedance and esophageal manometry, high-resolution manometry, 3-dimensional highresolution manometry, enoscopic functional luminal imaging probe, and 24-hour dynamic esophageal manometry, provide more information on esophageal motility and have clarified the pathophysiology of GERD. Proton pump inhibitors remain the preferred pharmaceutical option to treat GERD. The ideal target of GERD treatment is to restore esophageal motility and reconstruct the antireflux mechanism. This review focuses on current advances in esophageal motor dysfunction in patients with GERD and the influence of these developments on GERD treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5056/jnm19081

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Greater GERD duration causes increased erosive esophagitis, strictures, ulceration, and Barrett's esophagus.

    “Greater GERD duration causes increased erosive esophagitis, strictures, ulceration, and Barrett’s esophagus (Lin et al., 2019; Adanir et al., 2021).”

    From Thyroid disorders and gastrointestinal dysmotility: an old association (2024) · cites this paper as Lin et al., 2019

    The Introduction (page unavailable) says frequent and severe reflux may result in reflux esophagitis. The section on impaired esophageal clearance (page unavailable) also links prolonged acid exposure to esophagitis and related complications. Neither passage establishes that greater duration of GERD causes more complications, or specifically identifies strictures, ulceration, and Barrett’s esophagus as outcomes of longer GERD duration. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 70

  1. [1]Vakil N van Zanten SV Kahrilas P Dent J Jones R Global Consensus Group The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus Am J Gastroenterol 2006 101 1900 1920 10.1111/j.1572-0241.2006.00630.x 16928254 · DOI
  2. [2]Gyawali CP Roman S Bredenoord AJ Classification of esophageal motor findings in gastro-esophageal reflux disease: conclusions from an international consensus group Neurogastroenterol Motil 2017 29 1 15 10.1111/nmo.13104 28544357 · DOI
  3. [3]Sun X Ke M Wang Z Fang X Characteristics of esophageal motility in patients with non-erosive reflux disease and reflux esophagitis Zhonghua Yi Xue Za Zhi 2014 94 1718 1721 [Chinese] 25151902
  4. [4]Schneider JH Kuper MA Königsrainer A Brücher BL Transient lower esophageal sphincter relaxation and esophageal motor response J Surg Res 2010 159 714 719 10.1016/j.jss.2009.02.021 19577763 · DOI
  5. [5]Ergün M Doğan I Ünal S Ineffective esophageal motility and gastro-esophageal reflux disease: a close relationship? Turk J Gastroenterol 2012 23 627 633 10.4318/tjg.2012.0452 23794296 · DOI
  6. [6]Roman S Holloway R Keller J Validation of criteria for the definition of transient lower esophageal sphincter relaxations using high-resolution manometry J Neurogastroenterol Motil 2017 29 1 9 27477826
  7. [7]Pandolfino JE Zhang QG Ghosh SK Han A Boniquit C Kahrilas PJ Transient lower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry Gastroenterology 2006 131 1725 1733 10.1053/j.gastro.2006.09.009 17087957 · DOI
  8. [8]Sifrim D Holloway R Silny J Tack J Lerut A Janssens J Composition of the postprandial refluxate in patients with gastroesophageal reflux disease Am J Gastroenterol 2001 96 647 655 10.1111/j.1572-0241.2001.03598.x 11280529 · DOI
  9. [9]Trudgill NJ Riley SA Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers Am J Gastroenterol 2001 96 2569 2574 10.1111/j.1572-0241.2001.04100.x 11569677 · DOI
  10. [10]Iovino P Mohammed I Anggiansah A A study of pathophysiological factors associated with gastro-esophageal reflux disease in twins discordant for gastro-esophageal reflux symptoms Neurogastroenterol Motil 2013 25 650 656 10.1111/nmo.12137 23710904 · DOI
  11. [11]Kim HI Hong SJ Han JP Specific movement of esophagus during transient lower esophageal sphincter relaxation in gastroesophageal reflux disease J Neurogastroenterol Motil 2013 19 332 337 10.5056/jnm.2013.19.3.332 23875100 PMC3714411 · DOI
  12. [12]Beaumont H Bennink RJ de Jong J Boeckxstaens GE The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD Gut 2010 59 441 451 10.1136/gut.2009.178061 19651625 · DOI
  13. [13]Zentilin P Conio M Mele MR Comparison of the main oesophageal pathophysiological characteristics between short- and long-segment Barrett’s oesophagus Aliment Pharmacol Ther 2002 16 893 898 10.1046/j.1365-2036.2002.01237.x 11966497 · DOI
  14. [14]Akyüz F Uyanikoglu A Ermis F Gastroesophageal reflux in asymptomatic obese subjects: an esophageal impedance-pH study World J Gastroenterol 2015 21 3030 3034 10.3748/wjg.v21.i10.3030 25780302 PMC4356924 · DOI
  15. [15]Sun XH Ke MY Wang ZF Fang XC Role of diaphragmatic crural barrier and esophageal body clearance in patients with gastroesophageal reflux disease Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2002 24 289 293 [Chinese] 12905637
  16. [16]Nicodème F Pipa-Muniz M Khanna K Kahrilas PJ Pandolfino JE Quantifying esophagogastric junction contractility with a novel HRM topographic metric, the EGJ-contractile Integral: normative values and preliminary evaluation in PPI non-responders Neurogastroenterol Motil 2014 26 353 360 10.1111/nmo.12267 24460814 PMC4605557 · DOI
  17. [17]Tolone S De Bortoli N Marabotto E Esophagogastric junction contractility for clinical assessment in patients with GERD: a real added value? Neurogastroenterol Motil 2015 27 1423 1431 10.1111/nmo.12638 26227513 · DOI
  18. [18]Rengarajan A Bolkhir A Gor P Wang D Munigala S Gyawali CP Esophagogastric junction and esophageal body contraction metrics on high-resolution manometry predict esophageal acid burden Neurogastroenterol Motil 2018 30 e13267 10.1111/nmo.13267 29266647 · DOI
  19. [19]Pandolfino JE Curry J Shi G Joehl RJ Brasseur JG Kahrilas PJ Restoration of normal distensive characteristics of the esophagogastric junction after fundoplication Ann Surg 2005 242 43 48 10.1097/01.sla.0000167868.44211.f0 15973100 PMC1357703 · DOI
  20. [20]Pandolfino JE Shi G Trueworthy B Kahrilas PJ Esophagogastric junction opening during relaxation distinguishes nonhernia reflux patients, hernia patients, and normal subjects Gastroenterology 2003 125 1018 1024 10.1016/S0016-5085(03)01210-1 14517784 · DOI
  21. [21]Pandolfino JE Zhang Q Ghosh SK Post J Kwiatek M Kahrilas PJ Acidity surrounding the squamocolumnar junction in GERD patients: “acid pocket” versus “acid film” Am J Gastroenterol 2007 102 2633 2641 10.1111/j.1572-0241.2007.01488.x 17714553 · DOI
  22. [22]Fletcher J Wirz A Young J Vallance R McColl KE Unbuffered highly acidic gastric juice exists at the gastroesophageal junction after a meal Gastroenterology 2001 121 775 783 10.1053/gast.2001.27997 11606490 · DOI
  23. [23]Fletcher J Wirz A Henry E McColl KE Studies of acid exposure immediately above the gastro-oesophageal squamocolumnar junction: evidence of short segment reflux Gut 2004 53 168 173 10.1136/gut.2003.022160 14724145 PMC1774939 · DOI
  24. [24]Kwiatek MA Pandolfino JE Hirano I Kahrilas PJ Esophagogastric junction distensibility assessed with an endoscopic functional luminal imaging probe (EndoFLIP) Gastrointest Endosc 2010 72 272 278 10.1016/j.gie.2010.01.069 20541755 PMC3019759 · DOI
  25. [25]Chen JW Rubenstein JH Esophagogastric junction distensibility assessed using the functional lumen imaging probe World J Gastroenterol 2017 23 1289 1297 10.3748/wjg.v23.i7.1289 28275309 PMC5323454 · DOI
  26. [26]Weijenborg PW van Hoeij FB Smout AJ Bredenoord AJ Accuracy of hiatal hernia detection with esophageal high-resolution manometry Neurogastroenterol Motil 2015 27 293 299 10.1111/nmo.12507 25620528 · DOI
  27. [27]Kahrilas PJ Bredenoord AJ Fox M The Chicago classification of esophageal motility disorders, v3.0 Neurogastroenterol Motil 2015 27 160 174 10.1111/nmo.12477 25469569 PMC4308501 · DOI
  28. [28]Tolone S de Cassan C de Bortoli N Esophagogastric junction morphology is associated with a positive impedance-pH monitoring in patients with GERD Neurogastroenterol Motil 2015 27 1175 1182 10.1111/nmo.12606 26010058 · DOI
  29. [29]Ham H Cho YK Lee HH Esophagogastric junction contractile integral and morphology: two high-resolution manometry metrics of the anti-reflux barrier J Gastroenterol Hepatol 2017 32 1443 1449 10.1111/jgh.13720 28061013 · DOI
  30. [30]Pandolfino JE Kim H Ghosh SK Clarke JO Zhang Q Kahrilas PJ High-resolution manometry of the EGJ: an analysis of crural diaphragm function in GERD Am J Gastroenterol 2007 102 1056 1063 10.1111/j.1572-0241.2007.01138.x 17319930 · DOI
  31. [31]Kahrilas PJ McColl K Fox M The acid pocket: a target for treatment in reflux disease? Am J Gastroenterol 2013 108 1058 1064 10.1038/ajg.2013.132 23629599 · DOI
  32. [32]Spechler SJ Castell DO Classification of oesophageal motility abnormalities Gut 2001 49 145 151 10.1136/gut.49.1.145 11413123 PMC1728354 · DOI
  33. [33]Wu JC Cheung CM Wong VW Sung JJ Distinct clinical characteristics between patients with nonerosive reflux disease and those with reflux esophagitis Clin Gastroenterol Hepatol 2007 5 690 695 10.1016/j.cgh.2007.02.023 17481961 · DOI
  34. [34]Jiang L Ye B Wang Y Wang M Lin L Esophageal body motility for clinical assessment in patients with refractory gastroesophageal reflux symptoms J Neurogastroenterol Motil 2017 23 64 71 10.5056/jnm16047 27599539 PMC5216636 · DOI
  35. [35]Ribolsi M Balestrieri P Emerenziani S Guarino MP Cicala M Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients Am J Gastroenterol 2014 109 46 51 10.1038/ajg.2013.373 24189712 · DOI
  36. [36]Lei WY Hung JS Liu TT Yi CH Chen CL Altered oesophageal mechanosensitivity of secondary peristalsis as a pathophysiological marker in patients with globus sensation Clin Otolaryngol 2018 43 306 311 10.1111/coa.12978 28881108 · DOI
  37. [37]Chen CL Yi CH Liu TT Orr WC Effects of mosapride on secondary peristalsis in patients with ineffective esophageal motility Scand J Gastroenterol 2013 48 1363 1370 10.3109/00365521.2013.840856 24099237 · DOI
  38. [38]Chen CL Yi CH Liu TT Influence of intraluminal acidification on esophageal secondary peristalsis in humans Dig Dis Sci 2013 58 1948 1954 10.1007/s10620-013-2584-2 23392747 · DOI
  39. [39]Chen CL Yi CH Liu TT Relevance of ineffective esophageal motility to secondary peristalsis in patients with gastroesophageal reflux disease J Gastroenterol Hepatol 2014 29 296 300 10.1111/jgh.12367 23981079 · DOI
  40. [40]Yi CH Lei WY Hung JS Liu TT Chen CL Pace F Influence of capsaicin infusion on secondary peristalsis in patients with gastroesophageal reflux disease World J Gastroenterol 2016 22 10045 10052 10.3748/wjg.v22.i45.10045 28018112 PMC5143751 · DOI
  41. [41]Schoeman MN Holloway RH Integrity and characteristics of secondary oesophageal peristalsis in patients with gastro-oesophageal reflux disease Gut 1995 36 499 504 10.1136/gut.36.4.499 7737553 PMC1382486 · DOI
  42. [42]Page AJ Blackshaw LA Roles of gastro-oesophageal afferents in the mechanisms and symptoms of reflux disease Handb Exp Pharmacol 2009 227 257 10.1007/978-3-540-79090-7_7 19655109 · DOI
  43. [43]Lin S Li X Li H Refractory gastroesophageal reflux disease: pathophysiological basis revealed by 24-hour ambulatory pH-impedance-pressure monitoring Gastroenterology 2016 150 S473 10.1016/S0016-5085(16)31630-4 · DOI
  44. [44]Daum C Sweis R Kaufman E Failure to respond to physiologic challenge characterizes esophageal motility in erosive gastro-esophageal reflux disease Neurogastroenterol Motil 2011 23 517 e200 10.1111/j.1365-2982.2011.01669.x 21272162 · DOI
  45. [45]Cho YK Choi MG Lim CH Impaired esophageal bolus transit in patients with gastroesophageal reflux disease and abnormal esophageal Acid exposure Gut Liver 2012 6 440 445 10.5009/gnl.2012.6.4.440 23170147 PMC3493723 · DOI
  46. [46]Domingues GR Winograd R Lemme EM Characteristics of oesophageal bolus transport in patients with mild oesophagitis Eur J Gastroenterol Hepatol 2005 17 323 332 10.1097/00042737-200503000-00011 15716657 · DOI
  47. [47]Savarino E Gemignani L Pohl D Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease Aliment Pharmacol Ther 2011 34 476 486 10.1111/j.1365-2036.2011.04742.x 21671968 · DOI
  48. [48]Tutuian R Castell DO Clarification of the esophageal function defect in patients with manometric ineffective esophageal motility: studies using combined impedance-manometry Clin Gastroenterol Hepatol 2004 2 230 236 10.1016/S1542-3565(04)00010-2 15017607 · DOI
  49. [49]Nguyen NQ Tippett M Smout AJ Holloway RH Relationship between pressure wave amplitude and esophageal bolus clearance assessed by combined manometry and multichannel intraluminal impedance measurement Am J Gastroenterol 2006 101 2476 2484 10.1111/j.1572-0241.2006.00796.x 17029613 · DOI
  50. [50]Fornari F Bravi I Penagini R Tack J Sifrim D Multiple rapid swallowing: a complementary test during standard oesophageal manometry Neurogastroenterol Motil 2009 21 718 e41 10.1111/j.1365-2982.2009.01273.x 19222762 · DOI
  51. [51]Elvevi A Mauro A Pugliese D Usefulness of low- and high-volume multiple rapid swallowing during high-resolution manometry Dig Liver Dis 2015 47 103 107 10.1016/j.dld.2014.10.007 25458779 · DOI
  52. [52]Kushnir V Sayuk GS Gyawali CP Multiple rapid swallow responses segregate achalasia subtypes on high-resolution manometry Neurogastroenterol Motil 2012 24 1069 e561 10.1111/j.1365-2982.2012.01971.x 22788116 PMC3508286 · DOI
  53. [53]Martinucci I Savarino EV Pandolfino JE Vigor of peristalsis during multiple rapid swallows is inversely correlated with acid exposure time in patients with NERD Neurogastroenterol Motil 2016 28 243 250 10.1111/nmo.12719 26661383 · DOI
  54. [54]Martinucci I de Bortoli N Savarino E Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn Neurogastroenterol Motil 2014 26 546 555 10.1111/nmo.12299 24433456 · DOI
  55. [55]Frazzoni M Manta R Mirante VG Conigliaro R Frazzoni L Melotti G Esophageal chemical clearance is impaired in gastro-esophageal reflux disease-a 24-h impedance-pH monitoring assessment Neurogastroenterol Motil 2013 25 399 406 10.1111/nmo.12080 23360178 · DOI
  56. [56]Min YW Shin I Son HJ Rhee PL Multiple rapid swallow maneuver enhances the clinical utility of high-resolution manometry in patients showing ineffective esophageal motility Medicine (Baltimore) 2015 94 e1669 10.1097/MD.0000000000001669 26448010 PMC4616734 · DOI
  57. [57]Fock KM Talley N Goh KL Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus Gut 2016 65 1402 1415 10.1136/gutjnl-2016-311715 27261337 · DOI
  58. [58]Eslami O Shahraki M Bahari A Shahraki T Dietary habits and obesity indices in patients with gastro-esophageal reflux disease: a comparative cross-sectional study BMC Gastroenterol 2017 17 132 10.1186/s12876-017-0699-1 29179692 PMC5704630 · DOI
  59. [59]Sun X Shang W Wang Z Liu X Fang X Ke M Short-term and long-term effect of diaphragm biofeedback training in gastroesophageal reflux disease: an open-label, pilot, randomized trial Dis Esophagus 2016 29 829 836 10.1111/dote.12390 26227494 · DOI
  60. [60]Maradey-Romero C Fass R New and future drug development for gastroesophageal reflux disease J Neurogastroenterol Motil 2014 20 6 16 10.5056/jnm.2014.20.1.6 24466441 PMC3895610 · DOI
  61. [61]Kessing BF Smout AJ Bennink RJ Kraaijpoel N Oors JM Bredenoord AJ Prucalopride decreases esophageal acid exposure and accelerates gastric emptying in healthy subjects Neurogastroenterol Motil 2014 26 1079 1086 10.1111/nmo.12359 24891067 · DOI
  62. [62]Ndraha S Combination of PPI with a prokinetic drug in gastroesophageal reflux disease Acta Med Indones 2011 43 233 236 22156354
  63. [63]Nennstiel S Bajbouj M Schmid RM Becker V Prucalopride reduces the number of reflux episodes and improves subjective symptoms in gastroesophageal reflux disease: a case series J Med Case Rep 2014 8 34 10.1186/1752-1947-8-34 24502186 PMC3923556 · DOI
  64. [64]Yamashita H Kanamori A Fukuchi T Novel prokinetic acotiamide reduces transient lower esophageal sphincter relaxation in healthy subjects Digestion 2015 92 90 98 10.1159/000437301 26279051 · DOI
  65. [65]Seo KW Park MI Yoon KY Park SJ Kim SE Laparoscopic partial fundoplication in case of gastroesophageal reflux disease patient with absent esophageal motility J Gastric Cancer 2015 15 127 131 10.5230/jgc.2015.15.2.127 26161286 PMC4496439 · DOI
  66. [66]Broeders JA Sportel IG Jamieson GG Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplication Br J Surg 2011 98 1414 1421 10.1002/bjs.7573 21647868 · DOI
  67. [67]Shaker A Stoikes N Drapekin J Kushnir V Brunt LM Gyawali CP Multiple rapid swallow responses during esophageal high-resolution manometry reflect esophageal body peristaltic reserve Am J Gastroenterol 2013 108 1706 1712 10.1038/ajg.2013.289 24019081 PMC4091619 · DOI
  68. [68]Deprez P Fiasse R Healing of severe esophagitis improves esophageal peristaltic dysfunction Dig Dis Sci 1999 44 125 133 10.1023/A:1026614519572 9952233 · DOI
  69. [69]Ravi N Al-Sarraf N Moran T Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility Am J Surg 2005 190 445 450 10.1016/j.amjsurg.2005.05.040 16105534 · DOI
  70. [70]Xu JY Xie XP Song GQ Hou XH Healing of severe reflux esophagitis with PPI does not improve esophageal dysmotility Dis Esophagus 2007 20 346 352 10.1111/j.1442-2050.2007.00681.x 17617885 · DOI

Cited by

Sorted by citations

Authors
Lin, S., Li, H., & Fang, X.
Affiliations
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • First Affiliated Hospital of Xiamen University (CN)
Corresponding author
Fang, Xiucai
Venue
Journal of Neurogastroenterology and Motility
Published
2019-10-30
Volume
25
Issue
4
Pages
499-507
ISSN
  • 2093-0879 (ISSN-L)
  • 2093-0887
OpenAlex
W2977930428
Cited by
52
References
0
Citations by year
2026: 4 · 2025: 6 · 2024: 9 · 2023: 9 · 2022: 7 · 2021: 13 · 2020: 4
FWCI
1.09
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Journal of Neurogastroenterology and Motility (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
Keywords
gastroesophageal reflux disease, esophageal motility disorders, lower esophageal sphincter dysfunction, transient lower esophageal sphincter relaxations, esophageal hypersensitivity, esophageal peristalsis, hiatal hernia, antireflux surgery, proton pump inhibitors, high-resolution manometry, impedance-pH monitoring, esophageal clearance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review